Small Insider Sale: CRA International Director Reduces Stake
Rhea-AI Filing Summary
SEC Form 4 discloses that CRA International (CRAI) director Heather Tookes sold 88 common shares on 07/24/2025 at an average price of $177.03, generating proceeds of roughly $15.6k. Transaction code “S” denotes an open-market sale and was executed under a Rule 10b5-1 trading plan adopted on 03/14/2025. Following the sale, Tookes’ direct beneficial ownership stands at 3,051 shares. No derivative security activity was reported.
The filing represents a minor disposition—about 2.8% of her reported stake and an immaterial fraction of CRAI’s total shares outstanding—suggesting limited market impact. Use of a 10b5-1 plan indicates the transaction was pre-scheduled, reducing concerns about information asymmetry or negative signaling. No other executives or officers are listed, and the document contains no operational or financial performance data.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, pre-planned insider sale; negligible effect on valuation.
The director sold only 88 shares, leaving a 3,051-share position. This 2.8% trim is too small to infer confidence changes and was executed under a 10b5-1 plan, implying the trade was scheduled irrespective of near-term corporate developments. Given CRAI’s typical daily volume and market cap, proceeds of roughly $16k are immaterial. I view the filing as routine with no read-through for earnings or guidance.
TL;DR: Governance-neutral; 10b5-1 compliance mitigates insider-signal risk.
The disclosure shows adequate adherence to Section 16 reporting timelines and clarifies the use of a 10b5-1 plan, supporting transparency. The modest transaction size and continued sizable holding reduce concerns over commitment. There are no red flags relating to undisclosed pledging or derivative positions. Overall governance impact is neutral.